Study Comparing Pharmacokinetics of Different Formulations of Evobrutinib in Healthy Participants
Clinical trial NCT05245396 · COMPLETED
Trial details
- NCT number
- NCT05245396
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2023-02-14
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.